SG Americas Securities LLC Reduces Stock Position in Amicus Therapeutics, Inc. (NASDAQ:FOLD)
SG Americas Securities LLC lessened its stake in shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD – Get Rating) by 63.9% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 52,218 shares of the biopharmaceutical company’s stock after selling 92,568 shares during […]
Bradleyl Campbell Johnf Crowley Amicus Therapeutics Morgan Stanley Securities Exchange Commission Goldman Sachs Group Inc
Source: etfdailynews.com